Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Sens. Bernie Sanders and Amy Klobuchar's amendment allowing prescription drugs to be imported from Canada failed Wednesday night, with a vote of 46-52. But nearly a dozen members of each party broke with the other members of their party, making the issue surprisingly less about partisanship than individual members' views.
The idea behind importing drugs is it would create more competition on the market, driving down prices. But even if the amendment had passed, it was meaningless; it'd be attached to the budget resolution, which the president doesn't sign.
The takeaway: This was a test vote and shows how a similar bill would likely fare later, when it counts. But it also shows how weird the politics of prescription drug prices could get.